P139 Rituximab in a large UK centre during the COVID-19 pandemic: the effects of employing a reduced dosing regimen on clinical response in Rheumatoid Arthritis patients

McLorinan, J., Slade, M., Leong, C.-H. et al. (7 more authors) (2023) P139 Rituximab in a large UK centre during the COVID-19 pandemic: the effects of employing a reduced dosing regimen on clinical response in Rheumatoid Arthritis patients. In: British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2024, Manchester, UK.

Metadata

Item Type: Conference or Workshop Item
Authors/Creators:
Dates:
  • Published (online): 24 April 2023
  • Published: 24 April 2023
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Date Deposited: 27 Nov 2025 11:29
Last Modified: 27 Nov 2025 11:29
Published Version: https://academic.oup.com/rheumatology/article/62/S...
Status: Published
Identification Number: 10.1093/rheumatology/kead104.180
Related URLs:
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics

View Altmetric information about this item.


CORE (COnnecting REpositories)